Cookies on oxfam

We use cookies to ensure that you have the best experience on our website. If you continue browsing, we’ll assume that you are happy to receive all our cookies. You can change your cookie settings at any time. Find out more Accept

Trading Away Access to Medicines: How the European Union’s trade agenda has taken a wrong turn

Trading Away Access to Medicines: How the European Union’s trade agenda has taken a wrong turn
32 pages

Authors
Malpani, Rohit
Bloemen, Sophie

Publication date
20 Oct 2009

Publisher
Oxfam International
Health Action International Europe

Type
Briefing paper

Access to medicines poses a critical challenge in developing countries, largely because prices are high, and new or adapted medicines and vaccine to address diseases of the developing world are lacking. ore than 5 million people in low and middle income countries still lack access to the anti-retroviral medicines needed to treat HIV and AIDS. Non-communicable diseases (NCDs) have unleashed a new epidemic of suffering across the developing world. Pandemics are a serious threat in rich and poor countries alike, but while rich countries can stockpile medicines, these are often unaffordable for poor countries. Most people in developing countries pay for medicines out-of-pocket, so even a slight price increase can mean that life-saving medicines are unaffordable.

Comments